Company
Spineart
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
40
510(k), De Novo and PMA
Device trials
2
As lead sponsor, any status
Adverse event reports
21
Received Nov 1, 2025 to Nov 20, 2026
Recall records
13
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Spineart, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Spineart.
Latest FDA decisions
The 8 newest of 40 since 2015.
- SCALA® TL510(k)
K261049 · Decided Aug 20, 2026 · 142 days after receipt
Device type: Intervertebral Fusion Device With Bone Graft, Lumbar (MAX) · Orthopedic Surgery
39 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- A Clinical Trial Comparing the BAGUERA C to the Marketed Mobi-C® for the Treatment of Single Level Cervical Disc DiseasePivotal-lookingStatus unknown
NCT04520776 · 284 participants · Start Mar 2, 2021 · Primary completion Feb 2026
Device: BAGUERA®C Cervical Disc Prosthesis; Mobi-C® Cervical Disc · For: Cervical Disc Disease
Sites: Phoenix, Arizona; Scottsdale, Arizona; Laguna Hills, California · 27 sites in all
1 more trials with a free account
Reports received
21
Received Nov 1, 2025 to Nov 20, 2026. Includes 1 of another or unstated type.
Malfunction reports
11
52% of reports
Injury reports
9
43% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 1 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 1 | 0 | 0 | 0 |
| Jun 24 | 1 | 4 | 0 | 0 |
| Jul 24 | 0 | 1 | 0 | 0 |
| Aug 24 | 1 | 0 | 0 | 0 |
| Sep 24 | 2 | 1 | 0 | 0 |
| Oct 24 | 1 | 2 | 0 | 0 |
| Nov 24 | 1 | 0 | 0 | 0 |
| Dec 24 | 2 | 1 | 0 | 0 |
| Jan 25 | 1 | 1 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 0 | 2 | 0 | 0 |
| May 25 | 0 | 1 | 0 | 0 |
| Jun 25 | 0 | 2 | 0 | 0 |
| Jul 25 | 0 | 1 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 0 | 0 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 0 | 2 | 0 | 0 |
| Dec 25 | 0 | 1 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 1 | 0 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 | 0 |
| Apr 26 | 0 | 0 | 0 | 0 |
| May 26 | 0 | 1 | 0 | 0 |
| Jun 26 | 2 | 1 | 0 | 0 |
| Jul 26 | 7 | 3 | 0 | 1 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 1 | 1 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
3 more in this ranking with a free account
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2279-2025 · Started Jun 30, 2025 · Posted by FDA Aug 8, 2025
Reason given: Cannulated fenestrated polyaxial screws may be incorrectly labeled
Cause as FDA categorized it: Labeling Change Control · Device type: Thoracolumbosacral Pedicle Screw System (NKB)
12 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.